翰森制药集团是一家中国创新驱动型制药公司，致力于通过持续创新改善人类健康，重点关注抗肿瘤、抗感染、中枢神经系统类疾病、代谢疾病及自身免疫性疾病等治疗领域。

翰森制药集团

Hansyn Pharmaceutical Co., Ltd. | 933 followers on LinkedIn. Hansyn Pharmaceutical Co., Ltd is a pharmaceutical company committed to increasing access to high-quality healthcare by development and manufacture of generic drugs of active pharmaceutical ingredients.

Hansyn has cGMP veterinary drug production falicities and associated infra-structures producing veterinary ingredients such as Florfenicol and Thiamphenicol. Since 2012, Hansyn is entering human pharmaceutical area by investment of new cGMP multi-purpose plants (large scale plant, small scale plant, steroid plant), utility facilities, QC laboratories and R&amp;D Centers, planned to be finished by 2013.

Manufacturers of vet APIs and Intermediates: Marbofloxacin, Tulathromycin, Flunixin meglumine, Praziquantel, Sulfonamide series.…

Evon Shu

Hansyn Pharmaceutical Co., Ltd.

Domain Not Resolving

SSL by Default

Euro

Pound Sterling

Japanese Yen

GeoTrust SSL

China Telecom

Apache Tomcat Coyote

Business Management

Suisui Dong

Zhen Gong

Business Insight Manager

Echo Li

Healthcare

Xin Wang

Huijuan Huijuan

China Companies With More Than 100 Employees (Top 10K)

Asia-Pacific (APAC) Public Companies With More Than 500 Employees (Top 10K)

Asia Pharmaceutical Companies

Asia-Pacific (APAC) Biotechnology Public Companies

Hansoh Pharmaceutical Group  is a research and development driven pharmaceutical company in China. It holds a broad, diversified and leading drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further it also focuses on the gastrointestinal and cardiovascular therapeutic areas.

Lianyungang

Jiangsu

China

Asia

Hansoh Pharma

Hansoh Pharma patents new GLP-1R agonists

GSK’s Licensing Agreement with Hansoh Pharma for HS-20093

GSK Inks Potential $1.7B ADC Deal with China’s Hansoh Pharma

GSK’s Licensing Agreement with Hansoh Pharma

Everyone wants an ADC: GSK pays $85M upfront for ex-China rights to Hansoh Pharma's antibody-drug conjugate

Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration

Hansoh Pharma to Start China Trials of Novel Endometriosis Therapy

Pharmaceutical composition comprising third generation small molecule egfr …

Nitrogen-containing heterocyclic polycyclic compound, preparation method …

Silence Therapeutics announces siRNA collaboration with Hansoh Pharma

A drug used for the treatment of non-small cell lung cancer (NSCLC) with various applications including unresectable stage III NSCLC, adjuvant treatment post-surgery, and prevention of brain metastasis.

An orally administered small molecule KRAS G12C inhibitor for the treatment of advanced solid tumors, particularly NSCLC with KRAS G12C mutations.

A dual GIP and GLP-1 receptor agonist administered via subcutaneous injection for reducing glucose and body weight in patients with type 2 diabetes and overweight/obesity.

An antibiotic used for treating infections, specifically a nitroimidazole-class antibiotic.

A medication used for the treatment of schizophrenia and bipolar disorder.

A drug used for the treatment of chronic myeloid leukemia.

Pakistan

United States

North America

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 8:45 PM	c843e0ee
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 8:45 PM	8d7e15ed
crunchbase trigger	general	Nov 17, 2024 8:45 PM	2d499574
crunchbase profile	general	Nov 17, 2024 9:05 PM	f5715fe4
li profile	general	Nov 17, 2024 8:45 PM	73aebc45
translate crunchbase fundingrounds	general	Nov 17, 2024 9:30 PM	c3fbd366
peers	general	Nov 17, 2024 8:45 PM	a14d7534
news basic	general	Nov 17, 2024 8:45 PM	82a568af
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

HSPH

COM:HSPHARM:CN

翰森制药集团